ACA:EURONEXT PARIS

Credit Agricole SA

Data as of 2026-03-11 - not real-time

$108.24

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Arcosa, Inc. is trading at $108.24, well below its 20‑day SMA of $119.44 and 50‑day SMA of $115.91, indicating short‑term weakness despite a bullish trend direction. The RSI of 37 signals oversold conditions, while a bearish MACD histogram (-1.82) suggests momentum may still be negative. Volatility is high at 55.7% over 30 days and beta exceeds 1 (1.12), reflecting sensitivity to market moves. Valuation metrics show a trailing PE of 25.5 versus an industry average of 29.4, yet the DCF fair value of $2.14 per share implies the stock is significantly overvalued, with an upside/downside estimate of only +18% relative to current price. Analysts rate the stock as a strong buy with a mean target of $127.8, and the dividend yield is modest at 0.18% with an ultra‑low payout ratio of 4.7%, supporting dividend sustainability. Recent Q4 earnings reported a 7.6% revenue increase to $716.7 million and EPS growth to $1.15, beating the prior year, while the announced $450 million divestiture of the barge business enhances balance‑sheet flexibility. These fundamentals, combined with increasing volume trends, suggest the stock may rebound toward its $131 resistance level, but the current price remains near the $101.6 support.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term SMAs indicating near‑term support testing
  • Bearish MACD despite oversold RSI
  • Increasing volume suggesting potential accumulation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings beat and 7.6% revenue growth
  • Analyst consensus strong‑buy with ~18% upside
  • Dividend sustainability and low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic divestiture of barge business improving financial flexibility
  • Stable cash flow generation and moderate leverage
  • Sector tailwinds in infrastructure and construction markets

Key Metrics & Analysis

Financial Health

Revenue Growth7.60%
Profit Margin7.23%
P/E Ratio25.5
ROE8.22%
ROA3.92%
Debt/Equity59.91
P/B Ratio2.0
Op. Cash Flow$341.1M
Free Cash Flow$76.6M
Industry P/E29.4

Technical Analysis

TrendBullish
RSI37.1
Support$101.61
Resistance$131.00
MA 20$119.44
MA 50$115.91
MA 200$100.20
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value$2.14
Target Price$127.83
Upside/Downside18.10%
GradeOvervalued
TypeBlend
Dividend Yield0.18%

Risk Assessment

Beta1.12
Volatility55.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.